sk&f 104856 has been researched along with physostigmine heptyl in 1 studies
| Studies (sk&f 104856) | Trials (sk&f 104856) | Recent Studies (post-2010) (sk&f 104856) | Studies (physostigmine heptyl) | Trials (physostigmine heptyl) | Recent Studies (post-2010) (physostigmine heptyl) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 78 | 12 | 4 |
| Protein | Taxonomy | sk&f 104856 (IC50) | physostigmine heptyl (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 0.0135 | |
| Acetylcholinesterase | Mus musculus (house mouse) | 0.148 | |
| Acetylcholinesterase | Homo sapiens (human) | 0.0349 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camacho, F; Smith, CP; Vargas, HM; Winslow, JT | 1 |
1 other study(ies) available for sk&f 104856 and physostigmine heptyl
| Article | Year |
|---|---|
Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat.
Topics: Adrenergic alpha-Antagonists; Animals; Avoidance Learning; Benzazepines; Cholinesterase Inhibitors; Drug Synergism; Galantamine; Idazoxan; Male; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine; Yohimbine | 1996 |